Clinically obese means your body mass index (BMI) is 30 or higher. That’s the threshold where obesity becomes a formal medical diagnosis, complete with its own diagnostic codes, and where the statistical risk of conditions like type 2 diabetes, high blood pressure, and heart disease rises sharply. But BMI is just the starting point. A clinical obesity diagnosis can also factor in your waist circumference, body fat percentage, and whether weight-related health problems have already developed.
BMI Thresholds for Each Obesity Class
BMI is calculated by dividing your weight in kilograms by your height in meters squared. The CDC breaks adult obesity into three classes:
- Class 1 obesity: BMI of 30 to 34.9
- Class 2 obesity: BMI of 35 to 39.9
- Class 3 obesity (severe): BMI of 40 or higher
Class 3 was historically called “morbid obesity,” a term two healthcare providers coined in 1963 to justify insurance coverage for weight-loss surgery. That label is falling out of use because of its stigma, but you’ll still encounter it in older medical literature and some insurance documents.
For children and teens, a different standard applies. Because kids are still growing, their BMI is plotted against age-and-sex growth charts. A child is clinically obese when their BMI falls at or above the 95th percentile for their age group.
Why BMI Isn’t the Whole Picture
BMI doesn’t distinguish between muscle and fat, and it doesn’t tell you where fat is stored. Two people with the same BMI can have very different health profiles depending on whether fat sits around their organs or under the skin on their hips and thighs. That’s why clinicians often look at additional measures.
Waist circumference is one of the most practical. A waist measurement of 35 inches (88 cm) or more in women, or 40 inches (102 cm) or more in men, signals excess visceral fat, the metabolically active fat packed around internal organs that drives up risk for heart disease and diabetes. You can have a BMI in the “overweight” range and still carry dangerous visceral fat, or have a BMI over 30 with relatively lower metabolic risk.
Body fat percentage offers another lens. Recent research in the Journal of Clinical Endocrinology & Metabolism defines obesity as 30% body fat or higher in men and 42% or higher in women. Those thresholds were set by linking body fat levels to the point where metabolic problems like high blood sugar, abnormal cholesterol, and elevated blood pressure cluster together. For men, virtually no metabolic complications appear below 18% body fat. For women, that floor is around 30%.
How Obesity Is Staged Beyond Weight
A growing number of clinicians use systems that look past the scale entirely. The Edmonton Obesity Staging System, for instance, assigns a stage from 0 to 4 based on how much damage excess weight has already caused to your body and mind. Stage 0 means no detectable health issues despite having a high BMI. Stage 1 involves early warning signs: mildly elevated blood sugar, borderline blood pressure, or slightly off cholesterol numbers.
By Stage 2, obesity has triggered established conditions. Type 2 diabetes, diagnosed high blood pressure, sleep apnea, fatty liver disease, arthritis, depression, or anxiety. Stage 3 means significant organ damage: a previous heart attack, heart failure, stroke, or coronary artery disease. This approach matters because two people with identical BMIs of 38 can face wildly different health situations, and their treatment plans should reflect that.
The Health Risks at Each Level
The relationship between BMI and disease risk isn’t gradual. It accelerates. For every single-point increase in BMI, the risk of developing type 2 diabetes rises by about 20%. Once your BMI crosses roughly 29, your diabetes risk is already 300% higher than someone at a healthy weight. Obese individuals are 3.5 times more likely to develop high blood pressure, and an estimated 60 to 70% of high blood pressure cases in adults can be attributed to excess body fat.
Overall mortality risk increases too, though more modestly. A large meta-analysis covering 2.88 million people found obesity was associated with an 18% higher death rate. That figure may sound small on its own, but it compounds across decades and multiplies when combined with specific conditions like coronary artery disease or cancer.
Treatment Eligibility Tied to BMI
Your obesity class directly determines what treatments become available to you, which is one practical reason the clinical definition matters so much.
For prescription weight-loss medications, most guidelines set the bar at a BMI of 30 or higher. If your BMI is between 27 and 29.9, you may still qualify if you have at least one obesity-related condition like type 2 diabetes, high blood pressure, or high cholesterol. Some medications have higher thresholds. In the UK, for example, semaglutide is typically recommended starting at a BMI of 35, or 30 if you meet criteria for specialist weight management. Eligibility generally also requires that diet, exercise, and behavioral approaches haven’t produced sufficient results on their own.
For weight-loss surgery, the American Society of Metabolic and Bariatric Surgery recommends the procedure for anyone with a BMI over 35, regardless of whether other health problems are present. For people with a BMI between 30 and 34.9, surgery becomes an option if they have metabolic conditions like type 2 diabetes or if nonsurgical methods haven’t achieved lasting weight loss. These thresholds were lowered in 2022; previously, surgery typically required a BMI of 40 or 35 with comorbidities.
Ethnic and Individual Variation
Standard BMI cutoffs were developed primarily from data on white European populations, and they don’t apply equally to everyone. People of South Asian, Southeast Asian, and East Asian descent tend to develop metabolic complications at lower BMIs. Some clinical guidelines now use a BMI of 27.5 rather than 30 as the obesity threshold for these groups, and medication eligibility criteria in the UK explicitly account for ethnicity, lowering the required BMI by 2.5 points for people from minority ethnic backgrounds known to face equivalent health risks at lower weights.
This is part of a broader shift in how obesity is understood clinically. The number on the scale or the BMI calculator provides a useful screening tool, but the full clinical picture depends on where fat is distributed, what metabolic changes have already taken hold, and how your daily functioning and mental health are affected. A BMI of 30 is the line where the diagnosis begins, not where the assessment ends.